
J&J thought it could evade the anti-kickback statute because it signed an agreement that didn’t directly involve sales of Risperdal. The judge, however, said that contract was merely a “subterfuge” to disguise kickbacks meant to encourage the prescribing of Risperdal.
Full Article and Source:
JNJ May Be Liable for Antipsychotic Kickback Scheme
May be? I bet it's a lot more than may be!
ReplyDeleteFollow the money!
ReplyDeleteBig pharma is as powerful as the legal community.
ReplyDelete